Skip to content

Pharmacokinetic of hydrophilic antibiotics in critically ill

Optimized evaluation of glomerular filtration rate to target PK/PD of hydrophilic antibiotics in critically ill

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022434
Enrollment
Unknown
Registered
2019-04-11
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe infection in critically ill

Interventions

Grouped by different primary diseases and different pathophysiological staging in critically ill:beta-lactam antibiotics

Sponsors

Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Two types of patients with renal dysfunction 1.Meet any of the following criteria: 1) Augmented renal clearance (ARC) group:(50 patients for PK study and 50 patients for the group of dosing adjustment) a) Aged =50 years; b) Serum creatinine (Scr) 7 (age=50 years 6 scores; Trauma patients 3 scores; SOFA=4 1score); d) CLcr (8 hours)>130 mL /min; 2) Acute kidney injury group:( 50 patients for PK study and 50 patients for the group of dosing adjustment) a) Increase in Scr by 0.3mg/dl (26.5µmol/L) within 48 hours; b) Or increase in Scr to 1.5 times baseline, which is known or presumed to have occurred with in the prior 7 days; c) Or urine volume 0.5ml/kg/h for 6 hours. 2. Definite pathogen of infection. 3. Administration of hydrophilic antimicrobials. 4. The standard dosing of hydrophilic antimicrobials.

Exclusion criteria

Exclusion criteria: 1. Aged =18 years. 2. Renal replacement therapy. 3. Severe renal failure (eGFR 40 kg/m2).

Design outcomes

Primary

MeasureTime frame
targeted PK(f100%>MIC);

Secondary

MeasureTime frame
the rate of pathogenic bacteria elimination;

Countries

China

Contacts

Public ContactHongping Qu
hongpingqu0412@hotmail.com+86 15821968922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026